CD Bioparticles is a provider of drug-carrying contact lenses. Our experts specialize in develop a new generation of non-invasive drug delivery technologies that can overcome the ocular barrier for sustained drug release.
Topical drug delivery is the most widely preferred route of administration for the treatment of keratitis, conjunctivitis, dry eye, glaucoma, uveitis and other ophthalmic diseases. Drug-loaded contact lenses are a novel method of drug delivery by loading drug-active molecules (APIs) on a rigid or soft polymer device in contact with the cornea, continuously releasing the drug from the lens to the tear film, prolonging the residence time of the drug on the ocular surface, and improving bioavailability. Compared to traditional ocular drug delivery methods (eye drops, gels, etc.), contact lens-based drug delivery systems have the advantages of low drug side effects, high bioavailability, and ease of use.
Figure 1. Schematic illustration of drug release process realized by contact lens.1
With the advancement of DDS development, CD Bioparticles specialized researchers have achieved significant research results in the field of drug-loaded contact lens. We can offer you a wide range of services related to drug-loaded contact lens:
Quotations and Ordering
Reference
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.